{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:18:23Z","timestamp":1773836303224,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.autrev.2006.03.007","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T12:13:55Z","timestamp":1145535235000},"page":"42-47","source":"Crossref","is-referenced-by-count":51,"title":["Malignancies and soluble tumor antigens in rheumatic diseases"],"prefix":"10.1016","volume":"6","author":[{"given":"\u00c9va","family":"Szekanecz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csilla","family":"Andr\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsa","family":"S\u00e1ndor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Antal-Szalm\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Tam\u00e1si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emese","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2006.03.007_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002281-200301000-00007","article-title":"Rheumatic syndromes associated with malignancy","volume":"15","author":"Chakravarty","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00002281-200101000-00010","article-title":"Rheumatic syndromes: clues to occult neoplasia","volume":"13","author":"Nashitz","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3810\/pgm.2002.04.1162","article-title":"Cancer-associated neuromusculoskeletal syndromes","volume":"111","author":"Marmur","year":"2002","journal-title":"Postgrad Med"},{"key":"10.1016\/j.autrev.2006.03.007_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00002281-199102000-00020","article-title":"Rheumatic manifestations of neoplasia","volume":"3","author":"Schwarzer","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib5","first-page":"489","article-title":"Polymyositis","volume":"53","author":"Stertz","year":"1916","journal-title":"Berl Klin Wochenshr"},{"key":"10.1016\/j.autrev.2006.03.007_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0889-857X(21)00074-0","article-title":"Relationship of cancer to inflammatory muscle disease. Dermatomyositis, polymyositis and inclusion body myositis","volume":"20","author":"Callen","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2006.03.007_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-857X(05)70350-1","article-title":"Classification and treatment of the juvenile idiopathic inflammatory myopathies","volume":"23","author":"Rider","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2006.03.007_bib8","first-page":"101","article-title":"Dermatomyositis sine myositis: association with malignancy","volume":"23","author":"Whitmore","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib9","first-page":"1300","article-title":"Elevated cancer incidence in patients with dermatomyositis: a population based study","volume":"22","author":"Airio","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7326\/0003-4819-109-4-295","article-title":"A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome","volume":"109","author":"Freundlich","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2006.03.007_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/030097401316909486","article-title":"Rheumatic diseases and malignancy\u2014is there an association?","volume":"30","author":"Leandro","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/39.4.417","article-title":"Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies","volume":"39","author":"Hamidou","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2006.03.007_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.semnuclmed.2004.01.001","article-title":"Pulmonary hypertrophic osteoarthropathy and its resolution","volume":"34","author":"Shih","year":"2004","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.autrev.2006.03.007_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0145-2126(99)00151-4","article-title":"Relapsing polychondritis, smouldering non-secretory myeloma and early myelodysplastic syndrome in the same patient: three difficult diagnoses produce a life threatening illness","volume":"24","author":"Hall","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.autrev.2006.03.007_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2169\/internalmedicine.39.754","article-title":"Palmar fasciitis and polyarthritis associated with gastric carcinoma: complete resolution after total gastrectomy","volume":"39","author":"Enomoto","year":"2000","journal-title":"Int Med"},{"key":"10.1016\/j.autrev.2006.03.007_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000066758","article-title":"Pancreatic panniculitis in an 88-year-old man with neuroendocrine carcinoma","volume":"66","author":"Preiss","year":"2002","journal-title":"Digestion"},{"key":"10.1016\/j.autrev.2006.03.007_bib17","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2006.03.007_bib18","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.03.007_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.autrev.2006.03.007_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32A","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.autrev.2006.03.007_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","article-title":"Increased risk of cancer in patients with systemic lupus erythematosus","volume":"51","author":"Pettersson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2006.03.007_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/096120339300200608","article-title":"Malignancy in systemic lupus erythematosus","volume":"2","author":"Lopez Dupla","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2006.03.007_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.1780360405","article-title":"Cancer in systemic sclerosis","volume":"36","author":"Abu-Shakra","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.03.007_bib24","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"21","author":"Kinlen","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2006.03.007_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0049-0172(99)80026-2","article-title":"The incidence of cancer associated with the treatment of rheumatoid arthritis","volume":"29","author":"Beauparlent","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.03.007_bib27","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.03.007_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","article-title":"Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis but may be associated with an increased risk of lymphomas","volume":"64","author":"Geborek","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2006.03.007_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/clin.1995.1113","article-title":"Increased synovial expression of the adhesion molecules CD66a, CD66b and CD31 in rheumatoid and osteoarthritis","volume":"76","author":"Szekanecz","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2006.03.007_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-3083.1999.00602.x","article-title":"Enhanced expression of integrins and CD66b on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis and the effect of glucocorticoids","volume":"50","author":"Torsteinsdottir","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2006.03.007_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/rheumatology\/14.1.19","article-title":"Carcinoembryonic antigen in rheumatic diseases","volume":"14","author":"Unger","year":"1975","journal-title":"Rheumatol Rehabil"},{"key":"10.1016\/j.autrev.2006.03.007_bib32","first-page":"1410","article-title":"Elevation of tumor associated antigen CA19-9 levels in patients with rheumatic diseases","volume":"16","author":"Shimomura","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1346-8138.1995.tb03336.x","article-title":"Elevated serum CA125 in progressive systemic sclerosis with pleural effusion","volume":"22","author":"Kimura","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archderm.134.5.645","article-title":"Elevated circulating CA15.3 levels in a subset of systemic sclerosis with severe lung involvement","volume":"134","author":"Valerio-Marzano","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2006.03.007_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ageing\/30.2.171","article-title":"Markedly increased levels of IL-6 and CA125 in pleural fluids of an elderly person with overlap syndrome of systemic sclerosis and systemic lupus erythematosus","volume":"30","author":"Takeda","year":"2001","journal-title":"Age Ageing"},{"key":"10.1016\/j.autrev.2006.03.007_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/pgmj.74.875.543","article-title":"Increased serum CA19-9 antibodies in Sj\u00f6gren's syndrome","volume":"74","author":"Safadi","year":"1998","journal-title":"Postgrad Med J"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T22:01:43Z","timestamp":1627250503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997206000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1568997206000383"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2006.03.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}